News & Events
View all the latest news stories and events from Health Enterprise East plus a selection of other articles and events from partner agencies/organisations which may be of interest.
Health Enterprise East (HEE) and the Eastern AHSN recently hosted a Clinical Entrepreneurs Forum in Cambridge.
Awards go to novel technologies that aim to revolutionise primary care and GP services
Health Enterprise East are pleased to announce details of the Medtech Accelerator, created to help facilitate the early stage development of medical technology and software innovations from within the NHS that meet unmet clinical needs.
Medtech Accelerator - Proof of Concept Awards of between £15,000 and £125,000 are available to individuals or teams.
With the NHS facing unprecedented financial squeeze, improving the flow of patients, information and resources is crucial for driving up service quality and productivity, and improving patient experience.
£900K awarded to develop innovations that support self-care and independence in children with long term conditions.
With Accident and Emergency pressures well reported and as waiting times reach their highest level in more than a decade, SBRI Healthcare today announced £4.3 million investment in new technologies that could reduce pressures in this vital area.
Health Enterprise East supported project recruits first patients in trial at Addenbrooke’s Hospital, Cambridge.
NHS England has today (14 November 2016) revealed eight health innovations set to join year two of the NHS Innovation Accelerator, a scheme designed to help with the adoption of promising new treatments and technologies.
HEE’s CEO Dr Anne Blackwood was recently interviewed on Dynamic East - a new business series from Mustard TV.
Innovations from our Member Trusts and supported by Health Enterprise East, Pneumonia Prevention Systems & Atrial Connecting Systems, will for the first time be included under NHS national payment rules helping to accelerate uptake.The commitment to crea…
Spin out company raises £500k seed funding to progress development towards CE-marking and human studies
Setting out recommendations to speed up access to innovative healthcare and technologies, to improve efficiency and outcomes for NHS patients.
Game changing technologies needed to build General Practice of the future...
HEE's Dr Clare Beddoes - Senior Consultant, gives her expert overview in the September edition of ONdrugDelivery.
A great night was had by all who attended the Health Enterprise East Innovation Awards Ceremony, hosted by BBC Look East presenter Susie Fowler-Watt at the Radisson Blu Hotel London Stansted on Thursday 9th June..
Latest competition launch will award Phase 1 funding to accelerate development of new solutions towards better health outcomes..
Congratulations to the finalists of the HEE Innovation Awards 2016... Thanks to everyone who has entered this year's competition..
£1.4 million awarded to develop innovative new technologies that reduce pressures on A&E
Health Enterprise East, a provider of business and innovation management services to the NHS and industry, will be speaking at a number of leading industry events in the coming months..
Further £1 million awarded to develop innovative new technologies to help older people with multiple-morbidities.
Health Enterprise East (HEE), a provider of business and innovation management services to the NHS and industry, today announced the sale of its portfolio company, Northwood Medical Innovations Ltd, to Allergan plc (NYSE: AGN).
Health Enterprise East (HEE), a provider of business and innovation management services to the NHS and industry are pleased to announce the expansion of our team...
Health Enterprise East (HEE), the leading NHS Innovation Hub for the East of England, East Midlands and North London, announces a successful first year for its NHS Innovation Showcase, a one day event focussed on connecting academic, commercial and public …
SBRI Healthcare, an NHS England funded initiative to develop innovative products that address unmet health needs, today announced the 11 companies that have successfully reached the next phase (Phase 2) of the clinically-led competition.